Time to entry for new cancer medicines: from European Union wide marketing authorisation to patient access in Belgium, Estonia, Scotland, and Sweden

10 July 2018 - This study quantified the median time from European Union wide approval to first use for a ...

Read more →

Updated SMC guidance on comparator medicines with a patient access scheme

12 September 2016 - The SMC’s guidance to manufacturers about comparator medicines accepted for use on the basis of a confidential ...

Read more →